Interstitial Lung Disease Treatment Guidelines Aim to Relieve Patients’ Symptoms and Enhance Quality of Life
Various guidelines have been created for the treatment of interstitial lung disease, a group of conditions that cause the progressive scarring of lung tissue. As of this time, interstitial lung disease is incurable and the damage it causes cannot be reversed. Therefore, treatment generally is aimed at alleviating associated symptoms using a variety of methods, including the following:
- Anti-fibrotic medications
- Anti-inflammatory medications
- Immunosuppressive medications
- Nutrition counseling
- Pulmonary rehabilitation
- Supplemental oxygen therapy
One of the objectives of interstitial lung disease management is to create a personalized course of treatment specific to a patient’s unique needs. At the Lung Institute, we work toward achieving this goal by offering two different types of stem cell therapy: bone marrow therapy and venous therapy. Both types are geared toward slowing disease progression and improving quality of life.
Both of our stem cell therapy methods are performed in a clinical setting on an outpatient basis over the course of two days. Each method features specific benefits that allow us to choose the approach that will best suit a patient’s individual circumstances. For example, while bone marrow has been shown to contain more adult stem cells than peripheral blood, the process used to extract stem cells from a patient’s blood tends to be less invasive than that used for bone marrow therapy. Above all, our goal is to help our patients find a specialized plan of treatment that will allow them to breathe easier.
If you are living with interstitial lung disease, please contact the Lung Institute today at (800) 729-3065. We would be happy to provide you with additional information on interstitial lung disease treatment guidelines and help you determine whether stem cell therapy may be a beneficial addition to your course of treatment.